Use of Continuous Venovenous Hemofiltration for Reversal of Anticoagulation With Lepirudin Post-Cardiopulmonary Bypass in a Patient With Heparin-Induced Thrombocytopenia After Heart Transplantation

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 21, Issue 2, 2007, Pages 269-272

  Saravanan, Palanikumar ^a   Rege, Kanchan ^b   Falter, Florian ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

cardiopulmonary bypass; hemofiltration; heparin induced thrombocytopenia; hirudin; lepirudin

Indexed keywords

ANTICOAGULANT AGENT; APROTININ; DANAPAROID; DOPAMINE; FENTANYL; FRESH FROZEN PLASMA; HEPARIN; ISOFLURANE; ISOPRENALINE; LEPIRUDIN; MIDAZOLAM; PANCURONIUM; PROPOFOL; WARFARIN;

ADULT; ANESTHESIA; ANTIBIOTIC THERAPY; ANTICOAGULATION; AORTA BALLOON; ARTICLE; BLEEDING; BLOOD CLOTTING TIME; CARDIOMYOPATHY; CARDIOPULMONARY BYPASS; CASE REPORT; CONTINUOUS HEMOFILTRATION; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; IMMUNOASSAY; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; PATIENT CARE; PRIORITY JOURNAL; THROMBOCYTOPENIA;

ANTICOAGULANTS; CARDIOMYOPATHY, HYPERTROPHIC; CARDIOPULMONARY BYPASS; FEMALE; HEART FAILURE, CONGESTIVE; HEART TRANSPLANTATION; HEMOFILTRATION; HEPARIN; HIRUDINS; HUMANS; MIDDLE AGED; RECOMBINANT PROTEINS; THROMBOCYTOPENIA;

EID: 34047110335     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2006.04.003     Document Type: Article

References (27)

1. Pravinkumar E., and Webster N.R. HIT/HITT and alternative anticoagulation: Current concepts. Br J Anaesth 90 (2003) 676-685
2. Warkentin T.E., and Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 (2004) 311S-337S
3. von Segesser L.K., Mueller X., Marty B., et al. Alternatives to unfractionated heparin for anticoagulation in cardiopulmonary bypass. Perfusion 16 (2001) 411-416
4. Hourigan L.A., Walters D.L., Keck S.A., et al. Heparin-induced thrombocytopenia: A common complication in cardiac transplant recipients. J Heart Lung Transplant 21 (2002) 1283-1289
5. Shorten G.D., and Comunale M.E. Heparin-induced thrombocytopenia. J Cardiothorac Vasc Anesth 10 (1996) 521-530
6. Warkentin T.E., and Kelton J.G. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med 344 (2001) 1286-1292
7. Koster A., Crystal G.J., Kuppe H., et al. Acute heparin-induced thrombocytopenia type II during cardiopulmonary bypass. J Cardiothorac Vasc Anesth 14 (2000) 300-303
8. Greinacher A., Amiral J., Dummel V., et al. Laboratory diagnosis of heparin-associated thrombocytopenia and comparison of platelet aggregation test, heparin-induced platelet activation test, and platelet factor 4/heparin enzyme-linked immunosorbent assay. Transfusion 34 (1994) 381-385
9. Greinacher A., Michels I., Kiefel V., et al. A rapid and sensitive test for diagnosing heparin-associated thrombocytopenia. Thromb Haemost 66 (1991) 734-736
10. Griffiths E., and Dzik W.H. Assays for heparin-induced thrombocytopenia. Transfus Med 7 (1997) 1-11
11. Visentin G.P., and Aster R.H. Heparin-induced thrombocytopenia and thrombosis. Curr Opin Hematol 2 (1995) 351-357
12. Fondu P. Heparin-associated thrombocytopenia: An update. Acta Clin Belg 50 (1995) 343-357
13. Bauer T.L., Arepally G., Konkle B.A., et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation 95 (1997) 1242-1246
14. Warkentin T.E. Laboratory testing for heparin-induced thrombocytopenia. J Thromb Thrombolysis 10 suppl 1 (2000) 35-45
15. Risch L., Bertschmann W., Heijnen I.A., et al. A differentiated approach to assess the diagnostic usefulness of a rapid particle gel immunoassay for the detection of antibodies against heparin-platelet factor 4 in cardiac surgery patients. Blood Coagul Fibrinolysis 14 (2003) 99-106
16. Kappers-Klunne M.C., Boon D.M., Hop W.C., et al. Heparin-induced thrombocytopenia and thrombosis: A prospective analysis of the incidence in patients with heart and cerebrovascular diseases. Br J Haematol 96 (1997) 442-446
17. Hassell K. The management of patients with heparin-induced thrombocytopenia who require anticoagulant therapy. Chest 127 (2005) 1S-8S
18. Fischer K.G. Hirudin in renal insufficiency. Semin Thromb Hemost 28 (2002) 467-482
19. Potzsch B., Madlener K., Seelig C., et al. Monitoring of r-hirudin anticoagulation during cardiopulmonary bypass-Assessment of the whole blood ecarin clotting time. Thromb Haemost 77 (1997) 920-925
20. Koster A., Chew D., Grundel M., et al. Bivalirudin monitored with the ecarin clotting time for anticoagulation during cardiopulmonary bypass. Anesth Analg 96 (2003) 383-386
21. Edwards J.T., Hamby J.K., and Worrall N.K. Successful use of Argatroban as a heparin substitute during cardiopulmonary bypass: Heparin-induced thrombocytopenia in a high-risk cardiac surgical patient. Ann Thorac Surg 75 (2003) 1622-1624
22. Lewis B.E., Wallis D.E., Leya F., et al. Argatroban anticoagulation in patients with heparin-induced thrombocytopenia. Arch Intern Med 163 (2003) 1849-1856
23. Warkentin T.E., Chong B.H., and Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost 79 (1998) 1-7
24. Koster A., Pasic M., Bauer M., et al. Hirudin as anticoagulant for cardiopulmonary bypass: Importance of preoperative renal function. Ann Thorac Surg 69 (2000) 37-41
25. Frank R.D., Farber H., Lanzmich R., et al. In vitro studies on hirudin elimination by haemofiltration: Comparison of three high-flux membranes. Nephrol Dial Transplant 17 (2002) 1957-1963
26. Frank R.D., Farber H., Stefanidis I., et al. Hirudin elimination by hemofiltration: A comparative in vitro study of different membranes. Kidney Int Suppl 72 (1999) S41-S45
27. Koster A., Merkle F., Hansen R., et al. Elimination of recombinant hirudin by modified ultrafiltration during simulated cardiopulmonary bypass: Assessment of different filter systems. Anesth Analg 91 (2000) 265-269